Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;95:1417-1424

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolpers, H. G.
Right arrow Articles by Lichtlen, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolpers, H. G.
Right arrow Articles by Lichtlen, P. R.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
*Nuclear Scans

(Circulation. 1997;95:1417-1424.)
© 1997 American Heart Association, Inc.


Articles

Assessment of Myocardial Viability by Use of 11C-Acetate and Positron Emission Tomography

Threshold Criteria of Reversible Dysfunction

H. Georg Wolpers, MD; Wolfgang Burchert, MD; Jörg van den Hoff, PhD; Regina Weinhardt; Geert-J. Meyer, MD; Paul R. Lichtlen, MD

From the Department of Internal Medicine, Division of Cardiology (H.G.W., R.W., P.R.L.), and Department of Nuclear Medicine (W.B., J. van den H., G.-J.M.), Hannover Medical School, Germany.

Correspondence to H. Georg Wolpers, MD, Division of Cardiology, Hannover Medical School, Carl-Neuberg-Str 1, D-30625 Hannover, Germany.

Background Dual positron emission tomography (PET) imaging with a perfusion tracer and 18F-fluorodeoxyglucose (FDG) can detect myocardial viability. This approach may be replaced by a single 11C-acetate study, which enables quantification of both regional blood flow and oxidative metabolism. The significance of acetate-derived indexes for myocardial viability is examined.

Methods and Results Thirty postinfarct patients with akinetic ventricular segments, a mean ejection fraction of 42±11%, and high-grade coronary obstructions were studied with serial 11C-acetate PET scanning before and 7±5 months after coronary revascularization. Acetate PET was tested against FDG and serial assessments of segmental wall motion. Sixty of 155 severely dysfunctional LV segments improved postoperatively, and regional blood flow increased. Flow estimates after revascularization suggested little fibrosis in reversible segments. At baseline, blood flows differed between normal myocardium, reversible dysfunction, and irreversible dysfunction (1.04±0.27, 0.73±0.18, and 0.43±0.18 mL·min-1·g-1, respectively; P<.001). Oxidative metabolic rates were reduced only in irreversibly injured LV segments. Multivariate analysis identified the acetate perfusion index as the only independent predictor of postoperative recovery. Its predictive accuracy was similar to that of FDG imaging but superior to indexes of flow-metabolic mismatch or oxidative metabolism.

Conclusions After myocardial infarction, quantitative indexes of perfusion and oxidative metabolism from acetate PET indicate a critical threshold beyond which tissue is irreversibly injured. Findings support the use of blood flow as a marker of myocardial viability in chronic postinfarct patients with modestly reduced ejection fractions.


Key Words: regional blood flow • stunning, myocardial • myocardial infarction • metabolism




This article has been cited by other articles:


Home page
CirculationHome page
M. F. Di Carli and R. Hachamovitch
New Technology for Noninvasive Evaluation of Coronary Artery Disease
Circulation, March 20, 2007; 115(11): 1464 - 1480.
[Full Text] [PDF]


Home page
CirculationHome page
P. Knaapen, T. Germans, J. Knuuti, W. J. Paulus, P. A. Dijkmans, C. P. Allaart, A. A. Lammertsma, and F. C. Visser
Myocardial Energetics and Efficiency: Current Status of the Noninvasive Approach
Circulation, February 20, 2007; 115(7): 918 - 927.
[Full Text] [PDF]


Home page
JNMHome page
O. Lindner, J. Sorensen, J. Vogt, E. Fricke, D. Baller, D. Horstkotte, and W. Burchert
Cardiac Efficiency and Oxygen Consumption Measured with 11C-Acetate PET After Long-Term Cardiac Resynchronization Therapy
J. Nucl. Med., March 1, 2006; 47(3): 378 - 383.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Heusch, R. Schulz, and S. H. Rahimtoola
Myocardial hibernation: a delicate balance
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H984 - H999.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
O. Lindner, J. Vogt, A. Kammeier, P. Wielepp, J. Holzinger, D. Baller, B. Lamp, B. Hansky, R. Korfer, D. Horstkotte, et al.
Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy
Eur. Heart J., January 1, 2005; 26(1): 70 - 76.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M Egred, A Al-Mohammad, G D Waiter, T W Redpath, S K Semple, M Norton, A Welch, and S Walton
Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: blood oxygen level dependent (BOLD) MRI
Heart, July 1, 2003; 89(7): 738 - 744.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. van den Hoff, W. Burchert, A.-R. Borner, H. Fricke, G. Kuhnel, G. J. Meyer, D. Otto, E. Weckesser, H.-G. Wolpers, and W. H. Knapp
[1-11C]Acetate as a Quantitative Perfusion Tracer in Myocardial PET
J. Nucl. Med., August 1, 2001; 42(8): 1174 - 1182.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. F. Maes, F. Van de Werf, L. V. Mesotten, P. B. Flamen, R. S. Kuzo, J. L. Nuyts, and L. Mortelmans
Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 30 - 36.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Wiggers, M. Noreng, P. K. Paulsen, M. Bottcher, H. Egeblad, T. T. Nielsen, and H. E. Botker
Energy stores and metabolites in chronic reversibly and irreversibly dysfunctional myocardium in humans
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 100 - 108.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A Al-Mohammad, M Y Norton, I R Mahy, J C Patel, A E Welch, P Mikecz, and S Walton
Can the surface electrocardiogram be used to predict myocardial viability?
Heart, December 1, 1999; 82(6): 663 - 667.
[Abstract] [Full Text]


Home page
CirculationHome page
J. E. Olgin, H. J. Sih, S. Hanish, J. V. Jayachandran, J. Wu, Q. H. Zheng, W. Winkle, G. K. Mulholland, D. P. Zipes, and G. Hutchins
Heterogeneous Atrial Denervation Creates Substrate for Sustained Atrial Fibrillation
Circulation, December 8, 1998; 98(23): 2608 - 2614.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A Al-Mohammad, I R Mahy, M Y Norton, G Hillis, J C Patel, P Mikecz, and S Walton
Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles
Heart, December 1, 1998; 80(6): 559 - 564.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
G. HEUSCH
Hibernating Myocardium
Physiol Rev, October 1, 1998; 78(4): 1055 - 1085.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Schulz, C. Kappeler, H. Coenen, A. Bockisch, and G. Heusch
Positron Emission Tomography Analysis of [1-11C]Acetate Kinetics in Short-term Hibernating Myocardium
Circulation, March 17, 1998; 97(10): 1009 - 1016.
[Abstract] [Full Text] [PDF]